ABSTRACT
INTRODUCTION
Inflammation is a protective response of the human body against different stimulation, which may generate a series of the complex reaction. These events involve series of inflammatory mediators such as eicosanoids and other inflammatory mediators at inflammation site which are responsible for many connected disorders. 1 Non-steroidal anti-inflammatory drugs (NSAIDs) are the drug of choice for inflammation and its associated symptoms. However, these drugs over a period of usage showed unwanted effects, i.e., gastro-intestinal irritations and ulcers, kidney failure and Liver toxicity. 2 These shortcomings associated with NSAIDs can be avoided or lessened by replacing them with comparatively safer and effective plant-based drugs. 3 Complementary and alternative medicine (CAM) is gaining popularity in term of health and wellness therapy worldwide. It significantly reduces the cost of private and public health. Plant parts and its derived products are major sources of CAM. Moreover, the inadequacies of treatment options for prolonged inflammatory conditions like arthritis has led to the innovation of new medicinal agents from botanical sources. 4 Ayurvedic oils are extensively used for the treatment of joint diseases (Vatavyadhi, diseases essentially caused by Vata. 5 The Ayurvedic oil formulation such as Mahamash taila, Vishgarbha taila, Narayan taila, and Gandhapuro taila (oil of Gaultheria) are being used in the treatment of musculoskeletal pain and inflammatory condition such as arthritis. The main ingredient of Mahamash oil is Urad or black lentil along with Til taila (Sesame oil), Dashmool, Ashwagandha etc. Mahamash Tail is used as massage in treating various conditions such as tremors in hands, sciatica, muscular wasting of forearm, brachialgia.
is used since ages in various conditions such as neck rigidity/torticollis, lockjaw, muscle wasting. 6 Gandhapuro Taila is useful in conditions such as rheumatism, sciatica, acute pain of nervine origin. 8 The combination of these classical oils is expected to have an inherent benefit in various musculoskeletal symptoms associated with rheumatological and neurological conditions. The objective of these tests was to verify the anti-inflammatory and analgesic activity claim of a combination of these four well known Ayurvedic classical preparations together in a liniment dosage form.
MATERIALS AND METHODS

Chemical and Reagents
Preparation of Ayurvedic Liniment
The Zandu Rhumasyl Liniment coded as ZRL was prepared by mixing of four classical taila (oils) preparations namely Narayan taila, Mahamash taila, Vishgarbha taila and Gandhapuro taila (Oil of Gaultheria) each in equal quantity ( 
Animal
Wistar male rats (200 to 250 g) of were used for antiinflammatory studies. Swiss albino mice of either sex (47 ± 2 days) and a body mass index (BMI) between 20 and 38 g were for pain models. The animals were obtained from animal house of NSHM College Animal House, NSHM Knowledge campus, Kolkata, India. The rodents were kept for seven days in the pharmacology laboratory for acclimatization before initiating the experiments. The animals were grouped as eight per cage under standard environmental settings (12:12 h light: dark cycle at 25 ± 2° C); were fed with standardized pellet diet and water ad libitum. They were starved for 12 hours before experiments. The study was approved by the Institutional Animal Ethics Committee (CPCSEA Reg No. 1458/ PO/E/11/CPCSEA), and the experiments were conducted following the guidelines of committee for the purpose of control and supervision of experiments on animals (CPCSEA), Chennai, India.
Treatment Groups
Wistar rats of male sex were randomly assigned into three groups of five animals each for a single set of experiment. Group 1 animals were served as control and were treated with normal saline. Group 2 animals were treated on the plantar area of the hind paw with standard Volini Gel (Diclofenac sodium; Sun Pharmaceutical Industries Ltd.). The third test group (Group 3) was treated with ZRL formulation. During the course of an experiment, all animals were closely observed for apparent behavioral abnormalities.
Carrageenan-induced Paw Edema
Carrageenan (CA) induced rat paw edema was performed by the method of Winter et al. 9 Edema was induced in the plantar region of the right hind paw of rats by subcutaneous injection of 0.1 mL of freshly prepared carrageenan (1%) aqueous suspension in normal saline. The test and standard groups of rats received topical application of ZRL formulation and diclofenac (Volini Gel) respectively. The control group received vehicle (distilled water). Paw edema was induced by injecting carrageenan 60 minutes after the topical application. Plethysmometer was used to measure the paw volume at 0 hour (Vo before carrageenan injection) and hourly intervals till 5th hour (Vt). The change between Vt and Vo was taken as the edema value. The inhibition percentage was calculated as per the formula:
Tail Fick Method
Groups 1 and 3 served as control, standard and ZRL treated respectively. After 1 hour, the tail tip up to 5 cm was dipped into hot water being maintained at 58º C. The response time was documented as the sudden withdrawal of the tail from the hot water. Across the groups, a cut off time of 10 seconds was maintained to avoid damage to the tail. The time taken for the tail flick was recorded to assess response to the stimulus. Mice were placed for 10 minutes each day gently on a plate maintained at 25 ± 1º C for two consecutive days. On 3rd day , each mouse was kept quiet on a hot plate at 55 ± 1º C for a maximum period of 25 seconds. The baseline data for licking of forepaws and shaking or jumping Percent analgesia = (a-∂)×100/a Where a denotes after treatment reaction time and ∂ as baseline recording.
Statistics
Data were given as mean ± standard deviation (SD). Dataset was analyzed using t-test where the control group was compared with the sample treated group. Significance was fixed at p < 0.05, p < 0.01, p < 0.001.
RESULTS
Anti-inflammatory Activity
There was a significant reduction in the paw volume thickness after 3 hours with ZRL treatment for control. The percentage of reduction of paw volume after ZRL treatment and standard Volini Gel were 49.18 ± 2.92 and 81.79 ± 1.24 respectively (Fig. 1) .
Antinociceptive Activity
Tail Flick Test
After a latency period of one hour of ZRL topical application, there was a significant red uction to pain sensation. The anti-nociceptive property of the ZRL formulation was intense at 2 hours (Fig. 2 ). The results of the hotplate test revealed that the reaction time for the mice was significantly increased after treatment with ZRL (Fig 3) .
Eddy's Hot Plate Test
DISCUSSION
Zandu Rhumasyl is prepared with four oils (Taila) i.e. Narayan taila, Vishgarbha taila, Mahamash taila and Gandhapuro taila. Narayan taila, Mahamash taila and Vishgarbha taila are being referred in Ayurveda texts for management of Vatavyadhi (Neurological disorders). They have properties like Vedana sthapaka (analgesic), sosa (Wasting s) and sarvangagrahanam (stiffness and tightness in all limbs). Gandhapuro taila having properties of Uttejak (Stimulant) and Vatahar, and is useful as vednasthapak (analgesic) and in Arthritis (Amavata). These Tailas have also been scientifically studied to have potent analgesic and anti-inflammatory properties. Moreover, these oils are prepared by various combinations of herbs which also possess analgesic, anti-inflammatory, anodyne and emollient properties. [5] [6] [7] [8] They help in relieving pain and swelling and improve the mobility of joins, relax the muscles and improve the overall quality of life. Table 2 summarized the background of selection of four oils bas ed on its Ayurvedic usefulness in the treatment of musculoskeletal disorders related to rheumatological and neurological origin. As per Ayurvedic text, tail alleviates Vata and does not aggravate Kapha. It promotes body strength and provides firmness of muscles. Taila assimilates the properties of other drugs added to it during the paka of Sneha without losing its properties (Charka Samhita Sutrasthan 13/15). Carrageenan-generated paw edema is a recognized animal study design for acute inflammation. This design provided a noteworthy measurement for assessment of anti-edematogenic compounds working through a mechanism by interfering with the inflammatory mediators. 11 Carrageenan, an inflammatory agent, does not have any systemic activity. 12 Moreover, numerous scientists have established that acute inflammation occurred due to carrageenan injection has biphasic effects. In the first phase, histamine and serotonin have been stimulated to release in the systemic circulation, the later phase of inflammation, prostaglandins mainly responsible for modulating the edema. 13, 14 Experimental evidence indicated that during tenderness the prostaglandins increases the inflammatory exudates. The treatment of NSAIDs significantly reduces this inflammatory condition. 15 The series of evidence through various experiments revealed that ZRL formulation was effective in reducing this acute inflammation indicating its anti-inflammatory potential. However, the anti-inflammatory mechanisms of ZRL formulation are not yet established. Our observation suggested that ZRL formulation reduced the edema formation in the late phase showing the effectiveness of ZRL formulation possible inhibition of prostaglandins. Analgesic activity of medicines occurs through several mechanisms. ZRL was studied in different mouse models for its anti-nociceptive property. The thermal method is considered for centrally acting analgesics, e.g., opioid-like substances, mainly to understand the centrally acting anti-nociceptive mechanism at spinal and supraspinal levels. 16 The tail immersion/tail-flick response acts by spinal reflex and is considered as a specific screening tool for centrally acting analgesics. 17 Our results showed that ZRL formulation considerably delays the reaction time in tail flick test. The results are consistent with the interpretation that its analgesic property might have a central origin. These results showed that ZRL possessed analgesic activity. 
CLINICAL SIGNIFICANCE
The present experimental evidences on the marketed ZRL formulation have reconfirmed the traditional claims of its known ingredients mentioned in the Ayurveda texts.
The taila formulation has shown anti-inflammatory and analgesic activity and thereby authenticating its clinical use for management of pain associated with musculoskeletal and neurological disorders.
